Skip to content

Differences in unaffected skin of patients with hidradenitis suppurativa compared with healthy controls.

Differences in unaffected skin of patients with hidradenitis suppurativa compared with healthy controls. - Is HS healthy skin healthy?

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49510
Enrollment
20
Registered
2020-03-24
Start date
2020-04-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne inversa Verneuil's disease

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, HS patients must meet all of the following criteria: - Adults (* 18 years old) suffering from HS - Competent and willing to provide informed consent. In order to be eligible to participate in this study, healthy controls must meet all of the following criteria: - Adults (* 18 years old) not suffering from HS - Competent and willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria for HS patients: - Use of systemic or local antibiotics in the axillae or groin in the past 2 weeks - Use of any other medication potentially affecting the immune system or microbiome Exclusion criteria for healthy controls: -

Design outcomes

Primary

MeasureTime frame
Primary outcome: The difference in gene expression profile of unaffected skin from the axillae or groins of HS patients and healthy controls.

Secondary

MeasureTime frame
Secondary outcomes: 1. Microbial differences in uninvolved skin of HS axillae or groins and that of healthy controls. 2. Histological and immunohistochemical differences in uninvolved skin of HS axillae or groins and that of healthy controls

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)